Table 1.
The differences in general data and complications within 72 hours after operations, and the adverse events during a 4-year follow-up
| Items | Control | Treatment | P-value |
|---|---|---|---|
| General data before and within 72 hours after operations | |||
| Age (years) | 46.4±5.7 | 47.1±6.3 | >0.05 |
| WBC (×109) | 7.61±2.01 | 7.32±1.20 | >0.05 |
| PLT (×109) | 229.40±74.27 | 227.12±45.37 | >0.05 |
| Creatinine (µmol/L) | 76.81±5.44 | 75.43±6.37 | >0.05 |
| ALT (U/L) | 33.67±4.76 | 33.18±6.01 | >0.05 |
| Drainage (mL) | 572.15±47.23 | 504.81±60.48 | <0.05 |
| Healing time (days) | 18.2±1.1 | 17.7±2.7 | >0.05 |
| Complications within 72 hours after operations | |||
| Pain | 34.75% (11/32) | 31.25% (10/32) | >0.05 |
| Nausea | 25.00% (8/32) | 28.13% (9/32) | >0.05 |
| Vomiting | 12.50% (4/32) | 12.50% (4/32) | >0.05 |
| Diarrhea | 6.25% (2/32) | 3.13% (1/32) | >0.05 |
| Patients with exfoliated cancer cells | 12.50% (4/32) | 31.25% (10/32) | <0.05 |
| Adverse events during follow-up (4 years) | |||
| Recurrence | 3.13% (1/32) | 6.25% (2/32) | >0.05 |
| Metastasis | 0 (0/32) | 3.13% (1/32) | >0.05 |
Note: Patients in treatment group were treated with lobaplatin after cleaning procedures, followed by radical mastectomies for BCa patients.
Abbreviations: ALT, alanine aminotransferase; BCa, breast cancer; PLT, platelet count; WBC, white cell count.